Back to Search Start Over

Applying genomics in regulatory toxicology: a report of the ECETOC workshop on omics threshold on non-adversity

Authors :
Gant, T.W.
Auerbach, S.S.
von Bergen, Martin
Bouhifd, M.
Botham, P.A.
Caiment, F.
Currie, R.A.
Harrill, J.
Johnson, K.
Li, D.
Rouquie, D.
van Ravenzwaay, B.
Sistare, F.
Tralau, T.
Viant, M.R.
van de Laan, J.W.
Yauk, C.
Gant, T.W.
Auerbach, S.S.
von Bergen, Martin
Bouhifd, M.
Botham, P.A.
Caiment, F.
Currie, R.A.
Harrill, J.
Johnson, K.
Li, D.
Rouquie, D.
van Ravenzwaay, B.
Sistare, F.
Tralau, T.
Viant, M.R.
van de Laan, J.W.
Yauk, C.
Source :
ISSN: 0340-5761
Publication Year :
2023

Abstract

In a joint effort involving scientists from academia, industry and regulatory agencies, ECETOC’s activities in Omics have led to conceptual proposals for: (1) A framework that assures data quality for reporting and inclusion of Omics data in regulatory assessments; and (2) an approach to robustly quantify these data, prior to interpretation for regulatory use. In continuation of these activities this workshop explored and identified areas of need to facilitate robust interpretation of such data in the context of deriving points of departure (POD) for risk assessment and determining an adverse change from normal variation. ECETOC was amongst the first to systematically explore the application of Omics methods, now incorporated into the group of methods known as New Approach Methodologies (NAMs), to regulatory toxicology. This support has been in the form of both projects (primarily with CEFIC/LRI) and workshops. Outputs have led to projects included in the workplan of the Extended Advisory Group on Molecular Screening and Toxicogenomics (EAGMST) group of the Organisation for Economic Co-operation and Development (OECD) and to the drafting of OECD Guidance Documents for Omics data reporting, with potentially more to follow on data transformation and interpretation. The current workshop was the last in a series of technical methods development workshops, with a sub-focus on the derivation of a POD from Omics data. Workshop presentations demonstrated that Omics data developed within robust frameworks for both scientific data generation and analysis can be used to derive a POD. The issue of noise in the data was discussed as an important consideration for identifying robust Omics changes and deriving a POD. Such variability or “noise” can comprise technical or biological variation within a dataset and should clearly be distinguished from homeostatic responses. Adverse outcome pathways (AOPs) were considered a useful framework on which to assemble Omics

Details

Database :
OAIster
Journal :
ISSN: 0340-5761
Notes :
ISSN: 0340-5761, Archives of Toxicology 97 (8);; 2291 - 2302, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1406016233
Document Type :
Electronic Resource